Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
ZYXI

ZYXI - Zynex Inc Stock Price, Fair Value and News

$0.07-0.01 (-12.50%)
Market Closed

78/100

ZYXI

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

78/100

ZYXI

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$0.14

Target 3M

$0.11

Target 6M

$0.12

ZYXI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ZYXI Price Action

Last 7 days

-11.1%

Last 30 days

-38.5%

Last 90 days

-94.3%

Trailing 12 Months

-99.0%

ZYXI RSI Chart

ZYXI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ZYXI Valuation

Market Cap

2.1M

Price/Earnings (Trailing)

-0.03

Price/Sales (Trailing)

0.02

EV/EBITDA

0.16

Price/Free Cashflow

-0.1

ZYXI Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$0.14

Target 3M

$0.11

Target 6M

$0.12

ZYXI Fundamentals

ZYXI Revenue

Revenue (TTM)

108.2M

Rev. Growth (Yr)

-73.26%

Rev. Growth (Qtr)

-40.06%

ZYXI Earnings

Earnings (TTM)

-74.0M

Earnings Growth (Yr)

-1.9K%

Earnings Growth (Qtr)

-114.22%

ZYXI Profitability

EBT Margin

-65.57%

Return on Equity

-5.9K%

Return on Assets

-163.18%

Free Cashflow Yield

-987.07%

ZYXI Investor Care

Buy Backs (1Y)

4.57%

Diluted EPS (TTM)

-2.43

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025172.4M144.8M108.2M0
2024188.7M193.6M193.7M192.4M
2023169.3M177.4M185.8M184.3M
2022137.3M143.0M149.7M158.2M
202189.0M100.8M115.5M130.3M
202051.5M60.5M68.7M80.1M
201934.2M37.0M40.6M45.5M
201826.9M29.4M30.7M31.9M
201713.3M15.0M18.2M23.4M
201611.9M12.1M13.1M13.3M
201511.1M12.9M11.1M11.6M
201417.2M13.1M12.3M11.1M
201338.4M33.9M29.0M21.7M
201236.5M38.1M38.8M39.7M
201126.6M29.1M31.6M34.1M
201000024.1M
Get all data in R, Python etc through our Historical Stock Data APIs

About Zynex Inc

ZYXI
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
 CEO
 WEBSITEzynex.com
 SECTORHealthcare
 INDUSTRYMedical Distribution
 EMPLOYEES900

Zynex Inc Frequently Asked Questions

ZYXI is the stock ticker symbol of Zynex Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Tue Jan 27 2026, market cap of Zynex Inc is 2.13 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check ZYXI's fair value in chart for subscribers.

The fair value guage provides a quick view whether ZYXI is over valued or under valued. Whether Zynex Inc is cheap or expensive depends on the assumptions which impact Zynex Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ZYXI.

As of Tue Jan 27 2026, ZYXI's PE ratio (Price to Earnings) is -0.03 and Price to Sales (PS) ratio is 0.02. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ZYXI PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Zynex Inc has provided -0.129 (multiply by 100 for percentage) rate of return.